{"id":"NCT01009086","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis","officialTitle":"A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Aanti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-12","primaryCompletion":"2011-10","completion":"2013-05","firstPosted":"2009-11-06","resultsPosted":"2014-03-13","lastUpdate":"2015-03-03"},"enrollment":615,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Arthritis, Psoriatic"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Ustekinumab 45 mg","otherNames":[]},{"type":"DRUG","name":"Ustekinumab 90 mg","otherNames":[]}],"arms":[{"label":"Placebo","type":"EXPERIMENTAL"},{"label":"Ustekinumab 45 mg","type":"EXPERIMENTAL"},{"label":"Ustekinumab 90 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the effectiveness (improvement of signs and symptoms) and safety of ustekinumab in participants with active psoriatic arthritis.","primaryOutcome":{"measure":"Percentage of Participants With American College of Rheumatology (ACR) 20 Response at Week 24.","timeFrame":"Week 24","effectByArm":[{"arm":"Placebo","deltaMin":22.8,"sd":null},{"arm":"Ustekinumab 45 mg","deltaMin":42.4,"sd":null},{"arm":"Ustekinumab 90 mg","deltaMin":49.5,"sd":null},{"arm":"All Ustekinumab Combined","deltaMin":46,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":102,"countries":["United States","Australia","Austria","Canada","Finland","Germany","Hungary","Latvia","Lithuania","New Zealand","Poland","Russia","Spain","United Kingdom"]},"refs":{"pmids":["39120848","32209721","31070869","30739254","27483458","27098404","26097039","23769296"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":205},"commonTop":["Nasopharyngitis","Upper Respiratory Tract Infection","Hypertension","Psoriatic Arthropathy","Urinary Tract Infection"]}}